{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T22:55:28Z","timestamp":1772578528047,"version":"3.50.1"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2017,3,22]],"date-time":"2017-03-22T00:00:00Z","timestamp":1490140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2012\/17395-5"],"award-info":[{"award-number":["2012\/17395-5"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["307022\/2012-9"],"award-info":[{"award-number":["307022\/2012-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2017.00055","type":"journal-article","created":{"date-parts":[[2017,3,21]],"date-time":"2017-03-21T23:49:09Z","timestamp":1490140149000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["Transcriptome Analysis Showed a Differential Signature between Invasive and Non-invasive Corticotrophinomas"],"prefix":"10.3389","volume":"8","author":[{"given":"Leonardo Jose Tadeu","family":"de Ara\u00fajo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio Marcondes","family":"Lerario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"de Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clarissa Silva","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello Delano","family":"Bronstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcio Carlos","family":"Machado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ericka Barbosa","family":"Trarbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Candida Barisson","family":"Villares Fragoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2017,3,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1146\/annurev.pathol.4.110807.092259","article-title":"The pathogenesis of pituitary tumors","volume":"4","author":"Asa","year":"2009","journal-title":"Annu Rev Pathol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1530\/EJE-11-1095","article-title":"The burden of Cushing\u2019s disease: clinical and health-related quality of life aspects","volume":"167","author":"Feelders","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1210\/jc.84.8.2664","article-title":"Persistence of increased cardiovascular risk in patients with Cushing\u2019s disease after five years of successful cure","volume":"1","author":"Colao","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1590\/S0004-27302007000800025","article-title":"Cushing\u2019s syndrome: aftermath of the cure","volume":"51","author":"Pivonello","year":"2007","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"B5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-1-60327-449-4_2","article-title":"Etiologies of Cushing\u2019s syndrome","volume-title":"Cushing\u2019s Syndrome: Pathophysiology, Diagnosis and Treatment","author":"Newell-Price","year":"2010"},{"key":"B6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/neurosurgery\/16.CN_suppl_1.185","article-title":"Transphenoidal microsurgery of the normal and pathological pituitary","volume":"16","author":"Hardy","year":"1969","journal-title":"Clin Neurosurg"},{"key":"B7","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/cncr.20412","article-title":"The prevalence of pituitary adenomas: a systematic review","volume":"101","author":"Ezzat","year":"2004","journal-title":"Cancer"},{"key":"B8","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/nrendo.2014.64","article-title":"Aggressive pituitary adenomas-diagnosis and emerging treatments","volume":"10","author":"Di Leva","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s11060-014-1413-6","article-title":"Management of aggressive pituitary adenomas and pituitary carcinomas","volume":"117","author":"Heaney","year":"2014","journal-title":"J Neurooncol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/nou223","article-title":"CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007\u20132011","volume":"16","author":"Ostrom","year":"2014","journal-title":"Neuro Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1365-2265.2007.03168.x","article-title":"Role for postoperative cortisol response to desmopressin in predicting the risk for recurrent Cushing\u2019s disease","volume":"69","author":"Romanholi","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1210\/jc.2003-031489","article-title":"Cytoplasmic expression of fibroblast growth factor receptor-4 in human pituitary adenomas: relation to tumor type, size, proliferation, and invasiveness","volume":"89","author":"Qian","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B13","doi-asserted-by":"publisher","first-page":"E271","DOI":"10.1210\/jc.2010-0047","article-title":"Influence of the fibroblast growth factor receptor 4 expression and the G388R functional polymorphism on Cushing\u2019s disease outcome","volume":"95","author":"Brito","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1210\/me.2004-0182","article-title":"Pituitary tumor-derived fibroblast growth factor receptor 4 isoform disrupts neural cell-adhesion molecule\/N-cadherin signaling to diminish cell adhesiveness: a mechanism underlying pituitary neoplasia","volume":"18","author":"Ezzat","year":"2004","journal-title":"Mol Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1210\/me.2006-0223","article-title":"Targeting N-cadherin through fibroblast growth factor receptor-4: distinct pathogenetic and therapeutic implications","volume":"20","author":"Ezzat","year":"2006","journal-title":"Mol Endocrinol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1677\/erc.0.0070165","article-title":"Fibroblast growth factors, their receptors and signaling","volume":"7","author":"Powers","year":"2000","journal-title":"Endocr Relat Cancer"},{"key":"B17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/ng.3166","article-title":"Mutations in the deubiquitinase gene USP8 cause Cushing\u2019s disease","volume":"47","author":"Reincke","year":"2015","journal-title":"Nat Genet"},{"key":"B18","doi-asserted-by":"publisher","first-page":"E997","DOI":"10.1210\/jc.2015-1453","article-title":"The gene of the ubiquitin-specific protease 8 is frequently mutated in adenomas causing Cushing\u2019s disease","volume":"100","author":"Perez-Rivas","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B19","doi-asserted-by":"publisher","first-page":"E17","DOI":"10.3171\/2014.10.FOCUS14683","article-title":"Gene and protein expression in pituitary corticotroph adenomas: a systematic review of the literature","volume":"38","author":"Seltzer","year":"2015","journal-title":"Neurosurg Focus"},{"key":"B20","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1677\/ERC-08-0012","article-title":"Pituitary tumor-transforming gene in endocrine and other neoplasms: a review and update","volume":"15","author":"Salehi","year":"2008","journal-title":"Endocr Relat Cancer"},{"key":"B21","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1210\/jcem.84.2.5432","article-title":"Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas","volume":"84","author":"Zhang","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"B22","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.1038\/sj.onc.1202914","article-title":"hpttg is over-expressed in pituitary adenomas and other primary epithelial neoplasias","volume":"18","author":"S\u00e1ez","year":"1999","journal-title":"Oncogene"},{"key":"B23","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/j.1365-2265.2006.02630.x","article-title":"Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study","volume":"65","author":"Filippella","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing\u2019s syndrome: an endocrine society clinical practice guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1007\/s40618-016-0504-y","article-title":"Negative correlation between tumour size and cortisol\/ACTH ratios in patients with Cushing\u2019s disease harbouring microadenomas or macroadenomas","volume":"39","author":"Machado","year":"2016","journal-title":"J Endocrinol Invest"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1210\/jc.2002-021438","article-title":"Spoiled gradient recalled acquisition in the steady state technique is superior to conventional postcontrast spin echo technique for magnetic resonance imaging detection of adrenocorticotropin-secreting pituitary tumors","volume":"88","author":"Patronas","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"B27","first-page":"335","article-title":"Neurosurgical management of large and invasive pituitary tumors","volume-title":"Clinical Management of Pituitary Disorders","author":"Wilson","year":"1979"},{"key":"B28","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1097\/00006123-199310000-00008","article-title":"Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings","volume":"33","author":"Knosp","year":"1993","journal-title":"Neurosurgery"},{"key":"B29","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1677\/ERC-10-0018","article-title":"Differential gene expression profiles of invasive and non-invasive non-functioning pituitary adenomas based on microarray analysis","volume":"17","author":"Galland","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"B30","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","article-title":"Affy-analysis of Affymetrix GeneChip data at the probe level","volume":"20","author":"Gautier","year":"2004","journal-title":"Bioinformatics"},{"key":"B31","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"B32","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S1575-0922(10)70010-3","article-title":"Avances en biolog\u00eda molecular en patolog\u00eda neuroendocrina","volume":"57","author":"Casta\u00f1o","year":"2010","journal-title":"Endocrinolog\u00eda y Nutrici\u00f3n"},{"key":"B33","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1210\/jcem.86.7.7616","article-title":"Novel patterns of gene expression in pituitary adenomas identified by complementary deoxyribonucleic acid microarrays and quantitative reverse transcription-polymerase chain reaction 1","volume":"86","author":"Evans","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"B34","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.3760\/cma.j.issn.0366-6999.2010.23.015","article-title":"Differential gene expression by fiber-optic beadarray and pathway in adrenocorticotrophin-secreting pituitary adenomas","volume":"123","author":"Jiang","year":"2010","journal-title":"Chin Med J"},{"key":"B35","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1530\/eje.1.01937","article-title":"Differential gene expression in pituitary adenomas by oligonucleotide array analysis","volume":"153","author":"Morris","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1053\/gast.2001.24880","article-title":"Aberrant expression of G1-phase cell cycle regulators in flat and exophytic adenomas of the human colon","volume":"120","author":"Bartkova","year":"2001","journal-title":"Gastroenterology"},{"key":"B37","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1182\/blood.V87.1.324.324","article-title":"Molecular characterization of 12p abnormalities in hematologic malignancies: deletion of KIP1, rearrangement of TEL, and amplification of CCND2","volume":"87","author":"H\u00f6glund","year":"1996","journal-title":"Blood"},{"key":"B38","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1750-3639.1999.tb00532.x","article-title":"Amplification and expression of cyclin D genes (CCND1, CCND2 and CCND3) in human malignant gliomas","volume":"9","author":"B\u00fcschges","year":"1999","journal-title":"Brain Pathol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"5385","DOI":"10.1093\/hmg\/dds382","article-title":"Genome-wide meta-analysis points to CTC1 and ZNF676 as genes regulating telomere homeostasis in humans","volume":"21","author":"Mangino","year":"2012","journal-title":"Hum Mol Genet"},{"key":"B40","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.biocel.2004.10.012","article-title":"Cancer and aging: the importance of telomeres in genome maintenance","volume":"37","author":"Rodier","year":"2005","journal-title":"Int J Biochem Cell Biol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1021\/bi050229x","article-title":"Exploring the recognition of quadruplex DNA by an engineered Cys2-His2 zinc finger protein","volume":"45","author":"Ladame","year":"2006","journal-title":"Biochemistry"},{"key":"B42","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1146\/annurev-biochem-010909-095056","article-title":"The discovery of zinc fingers and their applications in gene regulation and genome manipulation","volume":"79","author":"Klug","year":"2010","journal-title":"Annu Rev Biochem"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1007\/s40618-015-0298-3","article-title":"Telomere length and telomerase expression in pituitary tumors","volume":"38","author":"Martins","year":"2015","journal-title":"J Endocrinol Invest"},{"key":"B44","first-page":"939","article-title":"Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients","volume":"61","author":"Rosas","year":"2001","journal-title":"Cancer Res"},{"key":"B45","first-page":"1031","article-title":"Frequent death-associated protein-kinase promoter hypermethylation in brain metastases of solid tumors","volume":"10","author":"Gonzalez-Gomez","year":"2003","journal-title":"Oncol Rep"},{"key":"B46","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1046\/j.1365-2141.2003.04644.x","article-title":"Frequent aberrant promoter hypermethylation of O6-methylguanine-DNA methyltransferase and death-associated protein kinase genes in immunodeficiency-related lymphomas","volume":"123","author":"Rossi","year":"2003","journal-title":"Br J Haematol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s000180050495","article-title":"Matrix metalloproteinases in tumor invasion","volume":"57","author":"Johansson","year":"2000","journal-title":"Cell Mol Life Sci"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.jocn.2015.02.021","article-title":"Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-2: prognostic biological markers in invasive prolactinomas","volume":"22","author":"G\u00fcltekin","year":"2015","journal-title":"J Clin Neurosci"},{"key":"B49","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/oxfordjournals.annonc.a010563","article-title":"Cyclin D1, another molecule of the year?","volume":"7","author":"Betticher","year":"1996","journal-title":"Ann Oncol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jnci.2011.11.003","article-title":"Differential expression of cyclin D1 in human pituitary tumors: relation to MIB-1 and p27\/Kip1 labeling indices","volume":"23","author":"Hewedi","year":"2011","journal-title":"J Egypt Natl Canc Inst"},{"key":"B51","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.wneu.2013.09.035","article-title":"Results of immunohistochemical staining of cell-cycle regulators: the prediction of recurrence of functioning pituitary adenoma","volume":"81","author":"Lee","year":"2014","journal-title":"World Neurosurg"},{"key":"B52","first-page":"2493","article-title":"Frequent loss of the P16INK4a gene product in human pituitary tumors","volume":"56","author":"Woloschak","year":"1996","journal-title":"Cancer Res"},{"key":"B53","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/path.833","article-title":"CDKN2A\/p16 inactivation is related to pituitary adenoma type and size","volume":"193","author":"Seemann","year":"2001","journal-title":"J Pathol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1530\/EJE-10-0245","article-title":"Upregulation of CDKN2A and suppression of cyclin D1 gene expressions in ACTH-secreting pituitary adenomas","volume":"163","author":"Tani","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e90396","DOI":"10.1371\/journal.pone.0090396","article-title":"Correlations of pituitary tumor transforming gene expression with human pituitary adenomas: a meta-analysis","volume":"9","author":"Xiao","year":"2014","journal-title":"PLoS One"}],"updated-by":[{"DOI":"10.3389\/fendo.2019.00567","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T00:00:00Z","timestamp":1566432000000}}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2017.00055\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T00:57:11Z","timestamp":1719104231000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2017.00055\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,22]]},"references-count":55,"alternative-id":["10.3389\/fendo.2017.00055"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2017.00055","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727566856.793549905","asserted-by":"object"}]},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,22]]},"article-number":"55"}}